Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

1.

Warfarin dose and the pharmacogenomics of CYP2C9 and VKORC1 - rationale and perspectives.

Yin T, Miyata T.

Thromb Res. 2007;120(1):1-10. Epub 2006 Dec 11. Review.

PMID:
17161452
[PubMed - indexed for MEDLINE]
2.

Pharmacogenetics of oral anticoagulants: a basis for dose individualization.

Stehle S, Kirchheiner J, Lazar A, Fuhr U.

Clin Pharmacokinet. 2008;47(9):565-94. Review.

PMID:
18698879
[PubMed - indexed for MEDLINE]
3.

Warfarin therapy: influence of pharmacogenetic and environmental factors on the anticoagulant response to warfarin.

Siguret V, Pautas E, Gouin-Thibault I.

Vitam Horm. 2008;78:247-64. doi: 10.1016/S0083-6729(07)00012-X. Review.

PMID:
18374198
[PubMed - indexed for MEDLINE]
4.

[Oral anticoagulation and pharmacogenetics: importance in the clinical setting].

Benusiglio PR, Desmeules J, de Moerloose P, Dayer P.

Rev Med Suisse. 2007 Sep 12;3(124):2030, 2033-4, 2036. Review. French.

PMID:
17955831
[PubMed - indexed for MEDLINE]
5.

Current pharmacogenetic developments in oral anticoagulation therapy: the influence of variant VKORC1 and CYP2C9 alleles.

Oldenburg J, Bevans CG, Fregin A, Geisen C, Müller-Reible C, Watzka M.

Thromb Haemost. 2007 Sep;98(3):570-8. Review.

PMID:
17849045
[PubMed - indexed for MEDLINE]
6.

Genetic influences on the response to warfarin.

Kamali F.

Curr Opin Hematol. 2006 Sep;13(5):357-61. Review.

PMID:
16888441
[PubMed - indexed for MEDLINE]
7.

The pharmocogenomics of warfarin: closing in on personalized medicine.

Rettie AE, Tai G.

Mol Interv. 2006 Aug;6(4):223-7. Review.

PMID:
16960144
[PubMed - indexed for MEDLINE]
8.

Evidence for a pharmacogenetic adapted dose of oral anticoagulant in routine medical practice.

Becquemont L.

Eur J Clin Pharmacol. 2008 Oct;64(10):953-60. doi: 10.1007/s00228-008-0542-2. Epub 2008 Aug 30. Review.

PMID:
18758764
[PubMed - indexed for MEDLINE]
9.

Oral anticoagulants: Pharmacogenetics Relationship between genetic and non-genetic factors.

D'Andrea G, D'Ambrosio R, Margaglione M.

Blood Rev. 2008 May;22(3):127-40. doi: 10.1016/j.blre.2007.11.004. Epub 2008 Jan 30. Review.

PMID:
18234403
[PubMed - indexed for MEDLINE]
10.

Pharmacogenomics of warfarin: uncovering a piece of the warfarin mystery.

Gulseth MP, Grice GR, Dager WE.

Am J Health Syst Pharm. 2009 Jan 15;66(2):123-33. doi: 10.2146/ajhp080127. Review.

PMID:
19139476
[PubMed - indexed for MEDLINE]
11.

[Pharmacogenetics of oral anticoagulants: individualized drug treatment for more efficacy and safety].

Loriot MA, Beaune P.

Rev Prat. 2007 Jun 30;57(12):1281-6. Review. French.

PMID:
17717937
[PubMed - indexed for MEDLINE]
12.

[Warfarin resistance and related pharmacogenetic information].

Takahashi H.

Brain Nerve. 2008 Nov;60(11):1365-71. Review. Japanese.

PMID:
19069171
[PubMed - indexed for MEDLINE]
13.

Pharmacogenetics of oral anticoagulants.

Daly AK, King BP.

Pharmacogenetics. 2003 May;13(5):247-52. Review.

PMID:
12724615
[PubMed - indexed for MEDLINE]
14.

Genetic regulation of warfarin metabolism and response.

Daly AK, Aithal GP.

Semin Vasc Med. 2003 Aug;3(3):231-8. Review.

PMID:
15199455
[PubMed - indexed for MEDLINE]
15.

Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumon.

Beinema M, Brouwers JR, Schalekamp T, Wilffert B.

Thromb Haemost. 2008 Dec;100(6):1052-7. Review.

PMID:
19132230
[PubMed - indexed for MEDLINE]
16.

Pharmacogenetics of warfarin: current status and future challenges.

Wadelius M, Pirmohamed M.

Pharmacogenomics J. 2007 Apr;7(2):99-111. Epub 2006 Sep 19. Review.

PMID:
16983400
[PubMed - indexed for MEDLINE]
17.

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing.

Johnson JA, Gong L, Whirl-Carrillo M, Gage BF, Scott SA, Stein CM, Anderson JL, Kimmel SE, Lee MT, Pirmohamed M, Wadelius M, Klein TE, Altman RB; Clinical Pharmacogenetics Implementation Consortium.

Clin Pharmacol Ther. 2011 Oct;90(4):625-9. doi: 10.1038/clpt.2011.185. Epub 2011 Sep 7. Review.

PMID:
21900891
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

[Possible application of pharmacogenomics to warfarin therapy].

Murata M.

Rinsho Byori. 2011 Jun;59(6):594-7. Review. Japanese.

PMID:
21815482
[PubMed - indexed for MEDLINE]
19.

Impact of VKORC1 gene polymorphism on interindividual and interethnic warfarin dosage requirement--a systematic review and meta analysis.

Yang L, Ge W, Yu F, Zhu H.

Thromb Res. 2010 Apr;125(4):e159-66. doi: 10.1016/j.thromres.2009.10.017. Epub 2009 Nov 25. Review.

PMID:
19942260
[PubMed - indexed for MEDLINE]
20.

Pharmacogenetics of vitamin K antagonists: useful or hype?

Lippi G, Franchini M, Favaloro EJ.

Clin Chem Lab Med. 2009;47(5):503-15. doi: 10.1515/CCLM.2009.140. Review.

PMID:
19397481
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk